APA ציטוט

Blanton, K. C., Deal, A. M., Kaiser-Rogers, K. A., Anders, C. K., O’Connor, S. M., Hertel, J. D., & Calhoun, B. C. (2020). Clinicopathologic Features of Breast Cancer Reclassified as HER2-Amplified by Fluorescence In Situ Hybridization with Alternative Chromosome 17 Probes. Ann Diagn Pathol.

Citação norma Chicago

Blanton, Kristen C., Allison M. Deal, Kathleen A. Kaiser-Rogers, Carey K. Anders, Siobhan M. O’Connor, Johann D. Hertel, and Benjamin C. Calhoun. "Clinicopathologic Features of Breast Cancer Reclassified As HER2-Amplified By Fluorescence In Situ Hybridization With Alternative Chromosome 17 Probes." Ann Diagn Pathol 2020.

ציטוט MLA

Blanton, Kristen C., et al. "Clinicopathologic Features of Breast Cancer Reclassified As HER2-Amplified By Fluorescence In Situ Hybridization With Alternative Chromosome 17 Probes." Ann Diagn Pathol 2020.

אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.